BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31455250)

  • 21. [The clinical characteristics and prognostic analysis of gastric mucosa-associated lymphoid tissue lymphoma of 103 cases].
    Li XW; Xia B; Guo Q; Jin X; Yu Y; Zhao ZG; Wang XF; Wang YF; Zhang YZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Oct; 33(10):805-9. PubMed ID: 23384898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helicobacter pylori infection as an independent prognostic factor for locally advanced gastric cancer patients treated with adjuvant chemotherapy after curative resection.
    Kang SY; Han JH; Ahn MS; Lee HW; Jeong SH; Park JS; Cho YK; Han SU; Kim YB; Kim JH; Sheen SS; Lim HY; Choi JH
    Int J Cancer; 2012 Feb; 130(4):948-58. PubMed ID: 21425257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Helicobacter pylori Eradication on Long-Term Survival after Distal Gastrectomy for Gastric Cancer.
    Kim YI; Cho SJ; Lee JY; Kim CG; Kook MC; Ryu KW; Kim YW; Choi IJ
    Cancer Res Treat; 2016 Jul; 48(3):1020-9. PubMed ID: 26582396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
    Chen LT; Lin JT; Tai JJ; Chen GH; Yeh HZ; Yang SS; Wang HP; Kuo SH; Sheu BS; Jan CM; Wang WM; Wang TE; Wu CW; Chen CL; Su IJ; Whang-Peng J; Cheng AL
    J Natl Cancer Inst; 2005 Sep; 97(18):1345-53. PubMed ID: 16174856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The clinical features, management and prognostic effects of pathological fractures in a multicenter series of 373 patients with diffuse large B-cell lymphoma of the bone.
    Govi S; Christie D; Messina C; Bruno Ventre M; Gracia Medina EA; Porter D; Radford J; Seog Heo D; Park Y; Martinelli G; Taylor E; Lucraft H; Ballova V; Zucca E; Gospodarowicz M; Ferreri AJ;
    Ann Oncol; 2014 Jan; 25(1):176-81. PubMed ID: 24287938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence of multiple abnormal immunologic markers is an independent prognostic factor of diffuse large B-cell lymphoma.
    Cao Y; Liu Z; Wu W; Qian Y; Shi Q; Shen R; Ouyang B; Xu P; Cheng S; Ye J; Lu Y; Wang C; Yang C; Wang L; Zhao W
    Front Med; 2019 Feb; 13(1):94-103. PubMed ID: 30706260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparison of Different Staging Systems and Prognostic Analysis in 68 Cases of Primary Intestinal Diffuse Large B Cell Lymphoma].
    Wang X; Wang CY; Xu W; Yang HL; Zhao HF; Wang XF; Wang YF; Yu Y; Zhang YZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Feb; 27(1):52-60. PubMed ID: 30738447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of follow-up endoscopic examination in treatment response assessment for patients with gastric diffuse large B cell lymphoma.
    Yoon SB; Lee IS; Lee HN; Kim E; Kim W; Lee HH; Lee BI; Choi MG; Jung SE; Choi BO; Park GS; Cho SG
    Scand J Gastroenterol; 2016 Sep; 51(9):1111-7. PubMed ID: 27175513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori eradication in gastric diffuse large B cell lymphoma.
    Paydas S
    World J Gastroenterol; 2015 Apr; 21(13):3773-6. PubMed ID: 25852262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer.
    Marrelli D; Pedrazzani C; Berardi A; Corso G; Neri A; Garosi L; Vindigni C; Santucci A; Figura N; Roviello F
    Cancer; 2009 May; 115(10):2071-80. PubMed ID: 19280589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori-related diffuse large B-cell lymphoma of the stomach: a distinct entity with lower aggressiveness and higher chemosensitivity.
    Kuo SH; Yeh KH; Chen LT; Lin CW; Hsu PN; Hsu C; Wu MS; Tzeng YS; Tsai HJ; Wang HP; Cheng AL
    Blood Cancer J; 2014 Jun; 4(6):e220. PubMed ID: 24949857
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive value of endoscopy and endoscopic ultrasonography for regression of gastric diffuse large B-cell lymphomas after Helicobacter pylori eradication.
    Tari A; Asaoku H; Kashiwado K; Yoshino T; Kitadai Y; Tanaka S; Fujihara M
    Dig Endosc; 2009 Oct; 21(4):219-27. PubMed ID: 19961519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastric cancer and Helicobacter pylori infection in the eastern Libya: a descriptive epidemiological study.
    Elzouki AN; Buhjab SI; Alkialani A; Habel S; Sasco AJ
    Arab J Gastroenterol; 2012 Jun; 13(2):85-8. PubMed ID: 22980598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prognostic impact of Helicobacter pylori infection and eradication therapy in gastric mucosa-associated lymphoid tissue lymphoma].
    Park SH; Chi HS; Park SJ; Jang S; Park CJ; Huh JR
    Korean J Lab Med; 2010 Dec; 30(6):547-53. PubMed ID: 21157137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A past history of gastric ulcers and Helicobacter pylori infection increase the risk of gastric malignant lymphoma.
    Suzuki T; Matsuo K; Ito H; Hirose K; Wakai K; Saito T; Sato S; Morishima Y; Nakamura S; Ueda R; Tajima K
    Carcinogenesis; 2006 Jul; 27(7):1391-7. PubMed ID: 16400189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of Helicobacter pylori eradication in the treatment of diffuse large B-cell and marginal zone lymphomas of the stomach.
    Ferreri AJ; Govi S; Ponzoni M
    Curr Opin Oncol; 2013 Sep; 25(5):470-9. PubMed ID: 23942292
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low HIP1R mRNA and protein expression are associated with worse survival in diffuse large B-cell lymphoma patients treated with R-CHOP.
    Wong KK; Ch'ng ES; Loo SK; Husin A; Muruzabal MA; Møller MB; Pedersen LM; Pomposo MP; Gaafar A; Banham AH; Green TM; Lawrie CH
    Exp Mol Pathol; 2015 Dec; 99(3):537-45. PubMed ID: 26341140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Profile and FDG-PET/CT Total Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B-Cell Lymphoma.
    Cottereau AS; Lanic H; Mareschal S; Meignan M; Vera P; Tilly H; Jardin F; Becker S
    Clin Cancer Res; 2016 Aug; 22(15):3801-9. PubMed ID: 26936916
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.
    Seo S; Hong JY; Yoon S; Yoo C; Park JH; Lee JB; Park CS; Huh J; Lee Y; Kim KW; Ryu JS; Kim SJ; Kim WS; Yoon DH; Suh C
    Oncotarget; 2016 Nov; 7(47):76934-76943. PubMed ID: 27764777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.